CEP
FLXN

Chicago Equity Partners’s Flexion Therapeutics, Inc. FLXN Stock Holding History

Chicago Equity Partners’s Portfolio FLXN Stock Details FLXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-54,009
Closed -$1.12M – 927
2019
Q4 		$1.12M Buy
+54,009
New +$911K 0.06% 427

Other funds holding FLXN

MVP
Miller Value Partners Sarasota, Florida $423M AUM 49.14% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
KCM
Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return
GS
Gagnon Securities New York $519M AUM 44.91% 1-Year Est. Return

Chicago Equity Partners's FLXN Position: Q1 2020 in Review

Chicago Equity Partners sold out of Flexion Therapeutics, Inc. (FLXN) in Q1 2020, closing a stake of 54,009 shares — an estimated $1.12M sold.

Chicago Equity Partners first reported a position in FLXN in Q4 2019 and held it in 1 quarter. The position peaked at $1.12M in Q4 2019. 123 funds tracked by Wall St. Rank hold FLXN as of Q1 2020.

  • Chicago Equity Partners reported no remaining Flexion Therapeutics, Inc. position as of Q1 2020 after selling out during the quarter.
  • Chicago Equity Partners sold 54,009 Flexion Therapeutics, Inc. shares in Q1 2020, an estimated $1.12M.
  • Chicago Equity Partners first reported a position in Flexion Therapeutics, Inc. in Q4 2019 and held it in 1 quarter.
  • Chicago Equity Partners's Flexion Therapeutics, Inc. position peaked at $1.12M in Q4 2019.
  • 123 funds tracked by Wall St. Rank held Flexion Therapeutics, Inc. as of Q1 2020.

Based on Chicago Equity Partners's 13F filing for Q1 2020, filed 6 May 2020.